Mary Harney is a company director with commercial experience, based on multiple years developing assets in oncology and the healthcare landscape. She has an understanding of academic and applied life science research, in addition to biopharmaceutical regulatory affairs and commercialization experience.
Ms Harney is the director of specialist consulting firm Mary Harney Advisory, providing leadership, governance and strategic advice across innovation industries such as health, biotech and agriculture.
She is chair of private Australian biotech CTxONE, a cancer drug discovery and development company pursuing novel epigenetic and immuno-oncology programs.
Ms Harney was the chief executive of Royal Australasian College of Surgeons and Gardiner Research Foundation, chief operating officer and director of the Office of Cancer Research for Peter MacCallum Hospital, and chief operating officer of Cerylid Biosciences.
In 2017, Ms Harney completed 'Strategy in the Age of Digital Disruption' at INSEAD Business School.
